Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals
- PMID: 28039870
- PMCID: PMC5484292
- DOI: 10.1111/jgs.14712
Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals
Abstract
Objectives: To estimate outcomes according to attained blood pressure (BP) in the oldest adults treated for hypertension in routine family practice.
Design: Cohort analysis of primary care inpatient and death certificate data for individuals with hypertension.
Setting: Primary care practices in England (Clinical Practice Research Datalink).
Participants: Individuals aged 80 and older taking antihypertensive medication and free of dementia, cancer, coronary heart disease, stroke, heart failure, and end-stage renal failure at baseline.
Measurements: Outcomes were mortality, cardiovascular events, and fragility fractures. Systolic BP (SBP) was grouped in 10-mmHg increments from less than 125 to 185 mmHg or more (reference 145-154 mmHg).
Results: Myocardial infarction hazards increased linearly with increasing SBP, and stroke hazards increased for SBP of 145 mmHg or greater, although lowest mortality was in individuals with SBP of 135 to 154 mmHg. Mortality of the 13.1% of patients with SBP less than 135 mmHg was higher than that of the reference group (Cox hazard ratio=1.25, 95% confidence interval=1.19-1.31; equating to one extra death per 12.6 participants). This difference in mortality was consistent over short- and long-term follow-up; adjusting for diastolic BP did not change the risk. Incident heart failure rates were higher in those with SBP less than 125 mmHg than in the reference group.
Conclusion: In routine primary care, SBP less than 135 mmHg was associated with greater mortality in the oldest adults with hypertension and free of selected potentially confounding comorbidities. Although important confounders were accounted for, observational studies cannot exclude residual confounding. More work is needed to establish whether unplanned SBPs less than 135 mmHg in older adults with hypertension may be a useful clinical sign of poor prognosis, perhaps requiring clinical review of overall care.
Keywords: hypertension; mortality; oldest old; outcomes; primary care.
© 2016 The Authors. The Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society.
Figures
Similar articles
-
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.J Hypertens. 2018 Aug;36(8):1622-1636. doi: 10.1097/HJH.0000000000001787. J Hypertens. 2018. PMID: 29847485 Review.
-
Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.JAMA Intern Med. 2014 Aug;174(8):1252-61. doi: 10.1001/jamainternmed.2014.2482. JAMA Intern Med. 2014. PMID: 24935209 Free PMC article.
-
Impact of lower achieved blood pressure on outcomes in hypertensive patients.J Hypertens. 2012 Apr;30(4):802-10; discussion 810. doi: 10.1097/HJH.0b013e3283516499. J Hypertens. 2012. PMID: 22343536 Clinical Trial.
-
Treatment of Hypertension: Which Goal for Which Patient?Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Adv Exp Med Biol. 2017. PMID: 27722961 Review.
-
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.J Hypertens. 2018 Feb;36(2):419-427. doi: 10.1097/HJH.0000000000001559. J Hypertens. 2018. PMID: 28938338
Cited by
-
Pharmacoepidemiologic study of association between apparent treatment resistant hypertension, cardiovascular disease and interaction effect by sex and age.World J Cardiol. 2023 May 26;15(5):262-272. doi: 10.4330/wjc.v15.i5.262. World J Cardiol. 2023. PMID: 37274374 Free PMC article.
-
Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents.J Am Geriatr Soc. 2023 Jul;71(7):2131-2140. doi: 10.1111/jgs.18301. Epub 2023 Feb 24. J Am Geriatr Soc. 2023. PMID: 36826917 Free PMC article.
-
Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials.J R Soc Med. 2023 Apr;116(4):133-143. doi: 10.1177/01410768231156997. Epub 2023 Feb 24. J R Soc Med. 2023. PMID: 36825537 Free PMC article.
-
Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases.Age Ageing. 2022 Jan 6;51(1):afab192. doi: 10.1093/ageing/afab192. Age Ageing. 2022. PMID: 34718378 Free PMC article.
-
Blood pressure, frailty status, and all-cause mortality in elderly hypertensives; The Nambu Cohort Study.Hypertens Res. 2022 Jan;45(1):146-154. doi: 10.1038/s41440-021-00769-0. Epub 2021 Oct 15. Hypertens Res. 2022. PMID: 34650194 Free PMC article.
References
-
- Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–2219. - PubMed
-
- James PA, Oparil S, Carter BL et al. 2014 evidence‐based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–520. - PubMed
-
- National Institute for Health and Care Excellence . Hypertension: Guidance and Guidelines. London, UK: National Institute for Health and Care Excellence, 2013.
-
- Weber MA, Schiffrin EL, White WB et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014;32:3–15. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
